At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.79B, above the global median of $1.14B
- PositionOperating margin is -121.6%, lower than 95% of its Medical Instruments & Supplies peers (median 12.4%)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.79BUSDvs all stocks (USD)
Revenue (TTM)
106.73MUSDvs all stocks (USD)
Profit Margin
-140.43%vs Medical Instruments & Supplies peers
52-Week Change
7.30%vs all stocks
Forward Annual Dividend Yield
0.00%vs all stocks
Market Capitalization
1.79BUSDvs all stocks (USD)
Enterprise Value
1.59BUSDvs all stocks (USD)
Forward P/E
-14.00xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
16.05xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
7.67xvs Medical Instruments & Supplies peers
Enterprise to Revenue
14.90xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-11.85xvs Medical Instruments & Supplies peers
Gross Margin
54.76%vs Medical Instruments & Supplies peers
Profit Margin
-140.43%vs Medical Instruments & Supplies peers
Operating Margin
-121.59%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-29.23%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-73.73%vs Medical Instruments & Supplies peers
Revenue (TTM)
106.73MUSDvs all stocks (USD)
Revenue per Share (TTM)
1.91USDUpdated Oct 27, 2026Quarterly Revenue Growth
59.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
57.51MUSDvs all stocks (USD)
EBITDA (TTM)
-134.18MUSDvs all stocks (USD)
Net Income (TTM)
-149.87MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
66.18%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
-87.72MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-72.03MUSDvs all stocks (USD)
Forward Annual Dividend Yield
0.00%vs all stocks
Trailing Annual Dividend Rate
0.00USDUpdated Oct 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Revenue
95.13MUSDFY2026 · Apr 30, 2026Cost of Goods Sold
46.26MUSDFY2026 · Apr 30, 2026Gross Profit
48.86MUSDFY2026 · Apr 30, 2026Operating Income
-134.74MUSDvs all stocks (USD)
Pre-tax Income
-131.32MUSDFY2026 · Apr 30, 2026Income Tax Expense
294.00KUSDFY2026 · Apr 30, 2026Net Income
-131.61MUSDFY2026 · Apr 30, 2026EBIT
-123.77MUSDFY2026 · Apr 30, 2026EBITDA (Income Statement)
-115.06MUSDFY2026 · Apr 30, 2026Research & Development
19.48MUSDFY2026 · Apr 30, 2026Selling, General & Administrative
164.12MUSDFY2026 · Apr 30, 2026Non-operating Interest Income
8.35MUSDFY2026 · Apr 30, 2026Non-operating Interest Expense
7.55MUSDFY2026 · Apr 30, 2026Net Income from Continuing Operations
-131.61MUSDFY2026 · Apr 30, 2026Operating Cash Flow
-92.75MUSDFY2026 · Apr 30, 2026Free Cash Flow
-128.17MUSDFY2026 · Apr 30, 2026Cash & Cash Equivalents (End of Period)
100.04MUSDFY2026 · Apr 30, 2026Income Tax Paid
13.00KUSDFY2026 · Apr 30, 2026Interest Paid
5.64MUSDFY2026 · Apr 30, 2026Starting Profit (CF Statement)
-131.61MUSDFY2026 · Apr 30, 2026Depreciation & Amortization
8.71MUSDFY2026 · Apr 30, 2026Deferred Taxes (CF)
166.00KUSDFY2026 · Apr 30, 2026Stock-based Compensation
33.64MUSDFY2026 · Apr 30, 2026Other Non-cash Items
2.20MUSDFY2026 · Apr 30, 2026Change in Accounts Receivable (CF)
-9.06MUSDFY2026 · Apr 30, 2026Change in Accounts Payable (CF)
4.30MUSDFY2026 · Apr 30, 2026Change in Other Assets/Liabilities
-1.10MUSDFY2026 · Apr 30, 2026Capital Expenditures
-35.42MUSDFY2026 · Apr 30, 2026Other Investing Activity
184.00KUSDFY2026 · Apr 30, 2026Net Investing Cash Flow
-35.24MUSDFY2026 · Apr 30, 2026Common Dividends Paid
-323.00KUSDFY2026 · Apr 30, 2026Other Financing Charges
-2.47MUSDFY2026 · Apr 30, 2026Net Financing Cash Flow
146.50MUSDFY2026 · Apr 30, 2026Shares Outstanding
58.38MSharesUpdated Oct 27, 2026Float Shares
33.72MSharesUpdated Oct 27, 2026Shares Short
3.28MSharesUpdated Oct 27, 2026Short Ratio
7.87daysvs all stocks
Short % of Shares Outstanding
11.68%vs all stocks
% Held by Insiders
5.22%vs all stocks
% Held by Institutions
101.77%vs all stocks
Total Cash (MRQ)
198.91MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
3.34USDUpdated Oct 27, 2026Total Debt (MRQ)
76.45MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.3438xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
4.69xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
3.75USDUpdated Oct 27, 2026Total Assets
358.46MUSDvs all stocks (USD)
Total Current Assets
222.36MUSDFY2026 · Apr 30, 2026Total Liabilities
98.81MUSDFY2026 · Apr 30, 2026Total Non-current Assets
136.11MUSDFY2026 · Apr 30, 2026Total Non-current Liabilities
48.44MUSDFY2026 · Apr 30, 2026Total Current Liabilities
50.37MUSDFY2026 · Apr 30, 2026Cash & Cash Equivalents
99.71MUSDFY2026 · Apr 30, 2026Accounts Receivable
14.54MUSDFY2026 · Apr 30, 2026Inventory
6.71MUSDFY2026 · Apr 30, 2026Accounts Payable
27.30MUSDFY2026 · Apr 30, 2026Short-term Debt
31.00KUSDFY2026 · Apr 30, 2026Long-term Debt
46.76MUSDFY2026 · Apr 30, 2026Other Non-current Liabilities
306.00KUSDFY2026 · Apr 30, 2026Common Stock (Book)
58.38MUSDFY2026 · Apr 30, 2026Retained Earnings
-651.86MUSDFY2026 · Apr 30, 2026Total Shareholders' Equity
259.66MUSDvs all stocks (USD)
52-Week Low
17.34USDUpdated Oct 27, 202652-Week High
30.42USDUpdated Oct 27, 202652-Week Change
7.30%vs all stocks
50-Day MA
26.48USDUpdated Oct 27, 2026200-Day MA
23.66USDUpdated Oct 27, 2026Avg 10-Day Volume
445.11KSharesUpdated Oct 27, 2026Avg 30-Day Volume
443.67KSharesUpdated Oct 27, 2026Diluted EPS (TTM)
-2.67USDUpdated Oct 27, 2026Other Income / Expense
2.62MUSDFY2026 · Apr 30, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -121.6%, lower than 95% of its Medical Instruments & Supplies peers (median 12.4%)Significant
Operating margin: -1.22Industry median: 0.12Industry P5: -0.14Peers compared: 57.00
Profit margin is -140.4%, lower than 95% of its Medical Instruments & Supplies peers (median 8.7%)Significant
Profit margin: -1.40Industry median: 0.09Industry P5: -0.25Peers compared: 57.00
Return on equity is -73.7%, lower than 95% of its Medical Instruments & Supplies peers (median 7.3%)Significant
Return on equity: -0.74Industry median: 0.07Industry P5: -0.24Peers compared: 57.00
Return on assets is -29.2%, lower than 95% of its Medical Instruments & Supplies peers (median 4.8%)Significant
Return on assets: -0.29Industry median: 0.05Industry P5: -0.12Peers compared: 57.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.55Profit Margin: -1.40
Financial Health
Altman Z-Score 8: safe zoneNotable
Altman Z-Score: 8.00
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.79B, above the global median of $1.14BNotable
Market cap (USD): 1,786,258,232Global Median: 1,137,180,293.291
Companies that share the same coordination system — how they create, deliver, or capture value.
Shandong Pharmaceutical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Crystal Clear Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Finolex Cables Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
GoodWe Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jinfu Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Lopal Tech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shanghai Anlogic Infotech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Guangdong Huicheng Vacuum Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Visteon Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Aerospace Shenzhou Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking